Tim Pearson, Elaine Sullivan. (LinkedIn, Carrick)
Tesaro vet jumps to an Irish oncology upstart and shifts focus to the US, eyeing fundraising
Tim Pearson’s biotech break is over.
After picking up a $12 million payout late last year following the sale of Tesaro to GSK, the former …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
